论文部分内容阅读
目的:探讨胰岛素泵用于治疗2型糖尿病(T2DM)的效果。方法:将88例T2DM患者随机分为观察组与对照组,各44例。观察组应用诺和锐30经胰岛素泵持续皮下输注,对照组应用诺和锐30每日3餐前皮下注射,比较两组的治疗效果。结果:两组治疗后FPG、2h PG及Hb Alc均显著降低(P<0.05),组间比较无明显差异(P>0.05);观察组的胰岛素平均用量及血糖达标时间均较对照组显著缩短(P<0.05)。结论:胰岛素泵治疗T2DM疗效与直接注射给药疗效相当,但能够减少胰岛素用量,且血糖达标时间明显缩短,操作更为简便,效价比更高,值得推广应用。
Objective: To investigate the effect of insulin pump on type 2 diabetes mellitus (T2DM). Methods: 88 cases of T2DM were randomly divided into observation group and control group, 44 cases in each. The observation group was given Novo Rui 30 insulin infusion pump subcutaneous infusion, the control group norvo Rui 30 daily 3 meals before subcutaneous injection, the treatment effect of the two groups were compared. Results: The levels of FPG, 2h PG and Hb Alc in the two groups were significantly decreased (P <0.05), and there was no significant difference between the two groups (P> 0.05). The mean insulin dosage and the time of reaching the standard of glycemic control in the observation group were significantly shorter than those in the control group (P <0.05). Conclusion: The curative effect of insulin pump in treating T2DM is equivalent to that of direct injection, but it can reduce insulin dosage, and the time of reaching the standard of blood sugar is obviously shortened. The operation is more convenient and the titer is higher. It is worth popularizing and applying.